Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 15:13:a26551320.
doi: 10.1055/a-2655-1320. eCollection 2025.

Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study

Affiliations

Optimal endoscopic resection method based on vertical margin distance for small rectal neuroendocrine tumors: Propensity score-matched study

Jianning Liu et al. Endosc Int Open. .

Abstract

Background and study aims: Advanced endoscopic resection methods are recommended for removing rectal neuroendocrine tumors (NETs) < 10 mm, but there is no consensus on optimal endoscopic technique. This study aimed to determine whether endoscopic mucosal resection with ligation (EMR-L) is superior to endoscopic submucosal dissection (ESD) in terms of efficacy and safety, focusing on achieving adequate vertical margin distance.

Patients and methods: This dual-center cohort study included consecutive patients with rectal NETs ≤ 10 mm. Adequate vertical margins were exploratively defined as a margin distance exceeding 115 μm, the 25th percentile threshold. Propensity score matching (PSM) was applied to compare outcomes between EMR-L and ESD.

Results: The study included 204 rectal NETs from 186 patients, with 61 lesions in each group after PSM. Compared with ESD, the EMR-L group demonstrated a higher R0 resection rate (98.4% vs. 83.6%, P = 0.021), a greater proportion of adequate vertical margins (80.3% vs. 62.3%, P = 0.030), and a lower rate of positive vertical margins (1.6% vs. 13.1%, P = 0.041). Subgroup analysis indicated that lesions ≤ 5 mm without prior biopsy or central depression derived greater benefit from EMR-L. Furthermore, EMR-L was associated with significantly shorter procedure times (median 5.0 vs. 19 minutes) and a markedly lower overall complication rate (8.2% vs. 29.5%, P = 0.005), particularly perforation (3.3% vs. 16.4%, P = 0.028).

Conclusions: EMR-L outperforms ESD for small rectal NETs by achieving higher R0 and better vertical margins in shorter times, while minimizing risk of perforation.

Keywords: CRC screening; Endoscopic resection (polypectomy, ESD, EMRc, ...); Endoscopy Lower GI Tract; Polyps / adenomas / ....

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
a,b A 57-year-old female with a 5-mm rectal neuroendocrine tumor, located 5 cm from the anal verge, underwent endoscopic mucosal resection with ligation (EMR-L). The postoperative vertical margin was 1040 μm, meeting the adequate margin standard. c,d A 50-year-old female with a 4-mm rectal neuroendocrine tumor, located 8 cm from the anal verge, underwent endoscopic submucosal dissection (ESD). The postoperative vertical margin was 90 μm, failing to meet the adequate margin standard.
Fig. 2
Fig. 2
Flowchart of the study design. EMR-L, endoscopic mucosal resection with ligation; ESD, endoscopic submucosal dissection; NET, neuroendocrine tumor.
Fig. 3
Fig. 3
Subgroup analysis Forrest plot of adequate vertical margin distance before and after propensity score matching (PSM). CI, confidence interval; EMR-L, endoscopic mucosal resection with ligation; ESD, endoscopic submucosal dissection; OR, odds ratio. The ESD group is used as the reference group.

Similar articles

References

    1. Sekiguchi M, Hotta K, Takeuchi Y et al. Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY. J Gastroenterol. 2022;57:547–558. - PubMed
    1. Dasari A, Shen C, Halperin D et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–1342. - PMC - PubMed
    1. Ngamruengphong S, Kamal A, Akshintala V et al. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors. Gastrointest Endosc. 2019;89:602–606. - PubMed
    1. Ramage JK, De Herder WW, Delle Fave G et al. ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms. Neuroendocrinology. 2016;103:139–143. - PubMed
    1. Tanaka S, Saitoh Y, Matsuda T et al. Evidence-based clinical practice guidelines for management of colorectal polyps. J Gastroenterol. 2021;56:323–335. doi: 10.1007/s00535-021-01776-1. - DOI - PMC - PubMed

LinkOut - more resources